Sell US-Iran nuclear deal: 49¢ thesis gap screams NO
E2 (Polymarket, 54¢) and E3 (Kalshi, 54¢) both price a US-Iran nuclear deal before 2027 at 54¢, while the underlying thesis implies just 5¢ fair value — a 49¢ raw edge and 31¢ effective edge. Cross-venue confirmation at identical prices rules out arb and confirms both venues are mispriced on the same thesis. The DOGE workforce-cut thesis implies US negotiating capacity is severely degraded, making a complex nuclear deal structurally unlikely. Sell NO on both E2 and E3 with a June 2026 reassessment trigger.
Hormuz normalization markets jumped +5¢ to 39¢ while US-Iran nuclear deal contracts sit at 54¢ on both Kalshi and Polymarket — yet thesis-implied fair value is just 5¢, creating a 49¢ effective edge on the NO side. Simultaneously, WTI prediction markets repriced sharply lower today (USO -2.24%), suggesting a de-escalation narrative is gaining traction that may be significantly overpriced. The tension between a potential deal (bearish oil, bearish Hormuz disruption) and continued military posture creates a directional edge on selling the deal probability.
CatalystUS-Iran nuclear deal announcement or collapse of talks by June 2026
RiskSurprise diplomatic breakthrough; back-channel deal leaks
WatchPrice converges below 15¢ on both venues · by 2026-06-30
US-Iran nuclear deal before 2027?
loading…sf ideas && sf book 0x182390641d3b1b47cc64274b9da290efd04221c586651ba190880713da6347d9